A carregar...
OS11.1 Temozolomide (TMZ) 1 week on/1 week off as initial treatment for high risk low grade oligodendroglial tumors: a phase II AINO (Italian Association for Neuro-Oncology) study
Introduction: The efficacy of dose-dense temozolomide (TMZ, 1 week on/1 week off) in grade II gliomas is not well known, and the impact could depend on the molecular subtype. In this regard prospective data are still missing. PATIENTS AND METHODS: Between 2006 and 2010 a single arm phase II study on...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5463642/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox036.072 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|